On Monday 4 and Tuesday 5 February 2019, the Academy of Medical Sciences hosted a two-day meeting on antimicrobial resistance (AMR). The meeting was organised as part of a wider programme of work which aims to strengthen the research links between the UK and India to jointly address the challenge of AMR.
Status: Launched
Read more
On Thursday 29 November 2018, the Academy of Medical Sciences and the French Académie Nationale de Médecine held a one-day symposium on mental health and addictions. at the Académie Nationale de Médecine in Paris.
Status: Launched
Read more
The Academy of Medical Sciences is undertaking a project exploring how the interface between academia and the NHS can be enhanced to improve the health and wealth of the UK.
Status: Ongoing
Read more
The Government has committed to increasing research and development (R&D) spending to 2.4% of GDP within the next 10 years, with a long-term goal of 3%. In this context the National Academies have recognised the need to better understand the benefits that R&I bring to the UK and how those benefits are achieved.
Status:
Read more
The Academy of Medical Sciences, the Medical Research Council and the National Insitute for Health Research are convening a one-day roundtable on 'Artificial intelligence and health' on 16 January 2019.
Status: Ongoing
Read more
Dr Irene Akua Agyepong delivered the 2018 Academy of Medical Sciences and The Lancet International Health Lecture under the title 'Universal Health Coverage: Global policy agenda breakthrough or great white elephant'?
Status: Launched
Read more
The preclinical-clinical boundary is a key checkpoint in the translational pathway for research. It refers to the point at which preclinical evidence is considered sufficient to merit the move to first-in-human clinical studies, and represents a significant escalation in both resourcing and time, with a high risk of failure. Therefore there is a drive to ensure that the evidence base for progression into clinical studies is as robust and predictive as possible to maximise the chances of success and minimise risk of failure.
Status: Undertaking Follow Up
Read more
One of the key ways to improve cancer outcomes is to detect and diagnose at an earlier stage when cancers are far more treatable. However, a limitation to the earlier diagnosis of some cancers is the lack of technologies that can detect very early indicators of disease. This means research into novel tests and innovations, and the rapid implementation of effective interventions into the healthcare system, are crucial.
Status: Undertaking Follow Up
Read more
The Academy of Medical Sciences, in collaboration with the Philippines National Academy of Science and Technology (NAST), convened a policy workshop on rapid diagnostic tests in South East Asia in Manila, Philippines on the 23-24 October 2018.
Status:
Read more
On 20 and 21 June 2018, the Academy hosted a two-day workshop on the topic of multimorbidity together with the MRC (now part of UKRI), the NIHR, and Wellcome.
Status:
Read more